Amwell targets 2026 adjusted EBITDA loss of (-$9M) to (-$7M) while forecasting Q3 revenue of $46M to $48M

EarningsNegative

AI Analysis

Summary

Amwell provided Q3 revenue guidance of $46M-$48M and targeted 2026 adjusted EBITDA losses of (-$9M) to (-$7M). The guidance indicates continued losses while forecasting modest revenue growth.

Financial Highlights

Revenue

$46M to $48M (Q3 guidance)

Guidance

2026 adjusted EBITDA loss of (-$9M) to (-$7M)

Importance:3/10

Sentiment:

-0.30

financial guidancetelemedicineEBITDA guidancerevenue forecast

Related Companies

$AMWL

Read the original article

Published by Seeking Alpha Healthcare on August 5, 2026 7:50 AM

Read Original